Capcom has released its review of fiscal year 2016, which ended in March. According to the company, Resident Evil continued to perform well for the company, both its re-releases and the latest installment, Resident Evil 7: Biohazard. A couple of other big names, however, didn't do quite as well as expected.

Capcom says Monster Generations was a solid seller overseas, and that the recently released Monster Hunter XX is "off to a promising start." That's in contrast to the youth-oriented Monster Hunter Stories and Dead Rising 4, which Capcom says "underperformed." Overall, Capcom's digital contents business had net sales of 58,704 million yen, which is up 11.7 percent over the previous fiscal year. Operating income was down 8.8 percent from last fiscal year, at 11,096 million yen.

Capcom as a whole, which also includes amusements, arcade games, and licensing ventures, had net sales of 87,170 million yen, an increase of 13.2 percent over the previous year.

Looking ahead, Capcom says it plans to continue exploring VR, as well as invest in its core business: games.

[Source: Capcom]

 

Our Take
Dead Rising has been a nice feather in Microsoft's cap, but if console exclusivity isn't as lucrative as Capcom had hoped, you have to wonder if it's something that will continue when (or if) the franchise continues.